Use of nonsteroidal anti-inflammatory drugs and biological agents for the treatment of axial spondyloarthritides. Recommendations of the spondyloarthritis study group of experts, All-Russian public organization "The association of rheumatology of Russia"
Автор: Gaidukova I.Z., Rebrov A.P., Lapshina S.A., Otteva E.N., Dubinina T.V., Badokin V.V., Bochkova A.G., Bugrova O.V., Godzenko A.A., Dubikov A.I., Ivanova O.N., Korotaeva T.V., Nesmeyanova O.B., Nikishina I.P., Raskina T.A., Rumyantseva O.A., Smirnov A.V., Sitalo A.V., Erdes Sh.F.
Журнал: Научно-практическая ревматология @journal-rsp
Рубрика: Международные и российские рекомендации по лечению ревматических заболеваний
Статья в выпуске: 5 т.55, 2017 года.
Бесплатный доступ
The paper gives recommendations for the drug therapy of axial spondyloarthritides, which have been developed by the Spondyloarthritis Study Group of Experts. The recommendations describe the patient management tactic in the most common clinical situations, which is aimed at maximizing the efficacy and safety of treatment.
Axial spondyloarthritides, ankylosing spondylitis, bechterew's disease, nonsteroidal anti-inflammatory drugs, tumor necrosis factor-а inhibitors, safety of therapy, spondyloarthritides, interleukin-17 inhibitors
Короткий адрес: https://sciup.org/14945850
IDR: 14945850 | DOI: 10.14412/1995-4484-2017-474-484
